Doxycycline inhibits breast cancer EMT and metastasis through PAR-1/NF-κB/miR-17/E-cadherin pathway.
about
Doxycycline inhibits breast cancer EMT and metastasis through PAR-1/NF-κB/miR-17/E-cadherin pathway.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Doxycycline inhibits breast ca ...... -κB/miR-17/E-cadherin pathway.
@en
Doxycycline inhibits breast ca ...... -κB/miR-17/E-cadherin pathway.
@nl
type
label
Doxycycline inhibits breast ca ...... -κB/miR-17/E-cadherin pathway.
@en
Doxycycline inhibits breast ca ...... -κB/miR-17/E-cadherin pathway.
@nl
prefLabel
Doxycycline inhibits breast ca ...... -κB/miR-17/E-cadherin pathway.
@en
Doxycycline inhibits breast ca ...... -κB/miR-17/E-cadherin pathway.
@nl
P2093
P2860
P356
P1433
P1476
Doxycycline inhibits breast ca ...... -κB/miR-17/E-cadherin pathway.
@en
P2093
Cheng Yang
Heng Zhang
Honggang Zhou
Hongzhi Wang
Huijuan Liu
Jingxia Han
Lingfei He
Longcong Huai
P2860
P304
104855-104866
P356
10.18632/ONCOTARGET.20418
P407
P577
2017-08-24T00:00:00Z